Chris@CNW, Author at CannabisNewsWire

MondayApr 29, 2024 10:00 am

Missouri AG Starts Investigating Intoxicating Hemp Derivatives

Earlier this week, Missouri’s AG began investigations in a bid to limit intoxicating hemp products. The issue, according to Attorney General Andrew Bailey, is products such as delta-8 vape pens and edibles, which aren’t labeled clearly for consumers. In his press release, the attorney general stated that people in Missouri had a right to know if the products they were buying had any serious or possibly dangerous side effects, such as hallucinations, severe confusion and psychotic episodes. Intoxicating products made from hemp are unregulated. Despite this, they are still sold in places such as gas stations and bars because hemp…

FridayApr 26, 2024 4:20 pm

420 with CNW — Maine Sounds Alarm on Illicit Marijuana Linked to Chinese Gangs

Maine is becoming the new hub for the illegal cannabis trade, with numerous unlicensed cultivation houses scattered across the state, according to a recent investigation conducted by CBS News. This trend mirrors a broader phenomenon unfolding countrywide, with illegal cannabis farms sprouting up in various states, such as Colorado, Oklahoma and California, as highlighted by the DEA’s former head of operations, Raymond Donovan. Donovan attributes Maine’s strategic suitability for marijuana cultivation to its discreet geographical location and proximity to prominent distribution hubs such as New York and Boston. A notable instance occurred in December when law enforcement authorities, after a…

FridayApr 26, 2024 10:00 am

A Decade Later, Colorado Voter Support for Cannabis Legalization Keeps Growing

New surveys show that more than 10 years after voters in Colorado passed a ballot initiative making it the first state in America to legalize adult-use cannabis sales, voters don’t regret their decision. Results from one poll conducted by the Colorado Polling Institute show that about 67% of registered voters saw the reform as a positive change for Colorado. This poll’s results were published in March. A separate poll carried out by Public Policy Polling (PPP) between April 8–9, 2024, determined that more than 71% of voters in the state thought marijuana needed to be legal and regulated in a…

ThursdayApr 25, 2024 4:20 pm

420 with CNW — Study Enumerates Therapeutic Effects, Quality of Life Benefits of Medical Cannabis

A recent publication in the “Medical Cannabis and Cannabinoids Journal,” authored by LECOM in collaboration with AYR Wellness (AYR), delves into the effects of medically approved cannabis on patients’ mental, social and physical well-being. The study showed that patients experienced notable enhancements across these domains, including increased energy levels, within the initial 30 days of treatment with medical cannabis. This study is the partnership’s first publication; four further studies examining the medical benefits of cannabis are in the works. The 90-day cohort study involved 103 adults (18 years of age and older) and was designed to evaluate the effects of…

WednesdayApr 24, 2024 4:20 pm

420 with CNW — Cannabis Taxes Are Underperforming Expectations in Several States

Approximately one-half of the U.S. population resides in states where recreational cannabis is legally accessible. Furthermore, 11 additional states, including Florida and Wisconsin, are contemplating legalization this year. One of the primary arguments for the legalization of cannabis is the potential for increased state tax income. However, the amount of revenue generated depends on the regulatory decisions made by each state regarding the cannabis industry and the method of taxation employed. Taxes on recreational cannabis typically revolve around factors such as potency, price, weight and quantity, similar to the taxation of other “sin products” such as alcohol and tobacco. Taxation…

WednesdayApr 24, 2024 10:00 am

Study Finds CBD Could Effectively Combat Crack-Use Disorder

New research has discovered that individuals who use CBD for crack-use disorder may have fewer adverse health events as well as better health outcomes. This is in comparison to patients who were on conventional treatments. For their study, the researchers conducted a double-blind, randomized, controlled trial where they compared CBD to clonazepam, valproic acid and fluoxetine, which are commonly used to treat crack use disorder. Study participants were 18 to 65 years of age and had either used crack at least 20 times in the last month, used it regularly for the last 12 months, or had an intention or…

WednesdayApr 24, 2024 9:00 am

Zoned Properties Inc. (ZDPY) Advancing Initiatives Through the Cannabis Sector

The cannabis industry supports communities through job creation, tax revenue generation, social equity programs, and community outreach initiatives ZDPY focuses on seizing direct-to-consumer real estate opportunities in the regulated cannabis market while enabling businesses to support the communities where they operate ZDPY's portfolio includes properties leased to licensed cannabis operators in Arizona, Illinois, and Michigan with 100% occupancy and a weighted average lease term of 10+ years ZDPY anticipates more than $2.5 million from its property investment portfolio in 2024 The cannabis industry supports the community through job creation, tax revenue generation for essential services, social equity programs, philanthropic efforts,…

TuesdayApr 23, 2024 4:20 pm

420 with CNW — California Authorities Seize Illicit Cannabis Worth $53M

California authorities recently conducted a comprehensive operation aimed at dismantling illegal marijuana operations across the state, seizing more than $53 million worth of illicit cannabis between Jan. 1, 2024, and March 31, 2024. The crackdown spearheaded by the state’s governor’s office targeted search warrants in various counties, including eight in Orange, one in San Joaquin, two in Riverside, one in Los Angeles, two in Alameda, five in Kern and one in Fresno. During the operation, law enforcement confiscated $53,620,600 worth of illegal marijuana along with 31,866 pounds of unlicensed product and 11 firearms. Additionally, approximately 54,137 unlicensed marijuana plants were…

MondayApr 22, 2024 4:20 pm

420 with CNW — FDA Boss Says DEA Doesn’t Have Reason to Delay Cannabis Rescheduling

U.S. Food and Drug Administration (FDA) director Robert Califf noted before a House committee on April 11, 2024, that there is no justification for the U.S. Drug Enforcement Administration (DEA) to postpone making the much-anticipated decision to move cannabis from Schedule I to III of the Controlled Substances Act (CSA). However, Califf suggested that the DEA might treat recreational cannabis differently from medical cannabis, a move that could significantly impact the American marijuana industry. Analysts have speculated on the implications of such a potential distinction, noting that it might result in tax advantages for medical cannabis enterprises over recreational ones.…

MondayApr 22, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third-party ethics review board GLP-1 drugs are utilized in the treatment of type 2 diabetes and obesity, a huge market, and are typically administered by painful and expensive injection, offering a major opportunity for Lexaria’s oral delivery platform This approval sets the company up for dosing within 30 days or less, with tentative study completion dates for this summer The study will comprise two study arms, the second study arm will investigate whether Lexaria’s patented DehydraTECH(TM)-enhanced semaglutide can effectively…